FR2644061B1 - - Google Patents

Info

Publication number
FR2644061B1
FR2644061B1 FR8903138A FR8903138A FR2644061B1 FR 2644061 B1 FR2644061 B1 FR 2644061B1 FR 8903138 A FR8903138 A FR 8903138A FR 8903138 A FR8903138 A FR 8903138A FR 2644061 B1 FR2644061 B1 FR 2644061B1
Authority
FR
France
Prior art keywords
composition
conbined
taurine
arterial
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8903138A
Other languages
English (en)
French (fr)
Other versions
FR2644061A1 (fr
Inventor
Covarrubias Jesus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MATIVELLE
Original Assignee
MATIVELLE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR8903138A priority Critical patent/FR2644061A1/fr
Application filed by MATIVELLE filed Critical MATIVELLE
Priority to CA002027593A priority patent/CA2027593C/fr
Priority to EP90400605A priority patent/EP0387140B1/fr
Priority to PCT/FR1990/000149 priority patent/WO1990010447A1/fr
Priority to DE69009538T priority patent/DE69009538T2/de
Priority to JP2504738A priority patent/JP2935138B2/ja
Priority to AT90400605T priority patent/ATE106733T1/de
Priority to KR1019900702419A priority patent/KR0169118B1/ko
Priority to ES90400605T priority patent/ES2058832T3/es
Priority to MX019819A priority patent/MX174250B/es
Publication of FR2644061A1 publication Critical patent/FR2644061A1/fr
Application granted granted Critical
Publication of FR2644061B1 publication Critical patent/FR2644061B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR8903138A 1989-03-10 1989-03-10 Composition a activite antiagregante plaquettaire utilisable en therapeutique Granted FR2644061A1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR8903138A FR2644061A1 (fr) 1989-03-10 1989-03-10 Composition a activite antiagregante plaquettaire utilisable en therapeutique
EP90400605A EP0387140B1 (fr) 1989-03-10 1990-03-06 Composition à activité anti-agrégante plaquettaire utilisable en thérapeutique
PCT/FR1990/000149 WO1990010447A1 (fr) 1989-03-10 1990-03-06 Composition a activite anti-agregante plaquettaire utilisable en therapeutique
DE69009538T DE69009538T2 (de) 1989-03-10 1990-03-06 In der Therapeutik anwendbare Zusammensetzung mit aggregationshemmender Wirkung auf Blutplättchen.
CA002027593A CA2027593C (fr) 1989-03-10 1990-03-06 Composition a activite anti-agregante plaquettaire utilisable en therapeutique
JP2504738A JP2935138B2 (ja) 1989-03-10 1990-03-06 治療に有用な血小板抗凝集効果を有する新しい組成物
AT90400605T ATE106733T1 (de) 1989-03-10 1990-03-06 In der therapeutik anwendbare zusammensetzung mit aggregationshemmender wirkung auf blutplättchen.
KR1019900702419A KR0169118B1 (ko) 1989-03-10 1990-03-06 치료에 유용한 혈소판 항-응집 효과를 갖는 조성물
ES90400605T ES2058832T3 (es) 1989-03-10 1990-03-06 Composicion con actividad anti-agregante plaquetaria utilizable en terapeutica.
MX019819A MX174250B (es) 1989-03-10 1990-03-09 Composicion con actividad antiagregante de plaqueta util en terapias

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8903138A FR2644061A1 (fr) 1989-03-10 1989-03-10 Composition a activite antiagregante plaquettaire utilisable en therapeutique

Publications (2)

Publication Number Publication Date
FR2644061A1 FR2644061A1 (fr) 1990-09-14
FR2644061B1 true FR2644061B1 (enExample) 1994-04-22

Family

ID=9379557

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8903138A Granted FR2644061A1 (fr) 1989-03-10 1989-03-10 Composition a activite antiagregante plaquettaire utilisable en therapeutique

Country Status (10)

Country Link
EP (1) EP0387140B1 (enExample)
JP (1) JP2935138B2 (enExample)
KR (1) KR0169118B1 (enExample)
AT (1) ATE106733T1 (enExample)
CA (1) CA2027593C (enExample)
DE (1) DE69009538T2 (enExample)
ES (1) ES2058832T3 (enExample)
FR (1) FR2644061A1 (enExample)
MX (1) MX174250B (enExample)
WO (1) WO1990010447A1 (enExample)

Also Published As

Publication number Publication date
JPH03504509A (ja) 1991-10-03
DE69009538T2 (de) 1995-01-12
KR0169118B1 (ko) 1999-01-15
EP0387140B1 (fr) 1994-06-08
WO1990010447A1 (fr) 1990-09-20
ES2058832T3 (es) 1994-11-01
ATE106733T1 (de) 1994-06-15
JP2935138B2 (ja) 1999-08-16
EP0387140A1 (fr) 1990-09-12
CA2027593A1 (fr) 1990-09-11
KR920700037A (ko) 1992-02-19
FR2644061A1 (fr) 1990-09-14
DE69009538D1 (de) 1994-07-14
MX174250B (es) 1994-05-02
CA2027593C (fr) 2001-01-02

Similar Documents

Publication Publication Date Title
GR3020036T3 (en) Inhibition of arterial thrombotic occlusion or thromboembolism
GR68727B (enExample)
KR950009098B1 (en) Pharmaceutical composition for use in treating clot formation
FI895769A7 (fi) Nahan käsittely selektoiduilla amfifiilisillä kopolymeereillä
NL192893B (nl) Casinotafelspel.
JPS5646809A (en) Glycolic acid oxidase inhibitor of 44*substituted thiazolyl**33hydroxyy33 pyrrolinee2*55dione
DK0424028T3 (da) S(+)-ibuprofen-L-aminosyre og S(+)-ibuprofen-D-aminosyre som et forbedret smertestillende middel med fremskyndet indtrædelse
ATE86490T1 (de) Tracheobronchodilatator.
ZA879011B (en) Variants of hirudin,their use and their preparation
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
NO921223L (no) Kombinasjonspreparat med antitrombotisk virkning
EP0305890A3 (en) Use of bezafibrate for the treatment of diabetes
NO894008L (no) Trekonserveringsmiddel og fremgangsmaate for behandling avtre med samme.
FR2644061B1 (enExample)
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
EP0430552A3 (en) Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
GR3008623T3 (enExample)
DE3852003D1 (de) Klöppel und Spannungsvorrichtung.
IL89901A0 (en) Strobilurine derivatives
ZA913920B (en) Therapeutic compound
DE68926334D1 (de) Textilbehandlungsmittel
DE3862486D1 (de) Fungizide mischungen mit prochloraz.
IT8840172A0 (it) Procedimento e mezzi per l'impressione in rilievo di tessuti, o pelli e simili
SE8701177L (sv) Arbetsmoebel med staellbart stativ
ATE82855T1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosidphosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.

Legal Events

Date Code Title Description
ST Notification of lapse